Search research articles
Contact Us
Filters
Showing results (181-190 of 721) with videos related to
Page
of 73
Sort By:
Oncology Research and Treatment
|
November 24, 2021
The Future Role of PET Imaging in Metastatic Breast Cancer
Kim M Pabst, Thomas Decker, David Kersting, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
May 1, 2020
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer
Lale Umutlu, Felix Nensa, Aydin Demircioglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 13, 2023
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
European Urology Oncology
|
April 25, 2019
Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments
Andrea Farolfi, Wolfgang Fendler, Amir Iravani, et al.
Data in Brief
|
March 5, 2021
Insights into immunometabolism: A dataset correlating the <sup>18</sup>FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer
Tugba Dönmez, Kerstin Höhne, Gernot Zissel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2017
<sup>18</sup>F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?
Julian Kirchner, Cornelius Deuschl, Johannes Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 19, 2019
In Vitro and In Vivo Characterization of an <sup>18</sup>F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts
Susanne Lütje, Gerben M Franssen, Ken Herrmann, et al.
Clinical Nuclear Medicine
|
December 30, 2014
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Rudolf A Werner, Joachim Brumberg, Alexander Dierks, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 24, 2017
Imaging children suffering from lymphoma: an evaluation of different <sup>18</sup>F-FDG PET/MRI protocols compared to whole-body DW-MRI
Julian Kirchner, Cornelius Deuschl, Bernd Schweiger, et al.
Asian Cardiovascular & Thoracic Annals
|
July 13, 2023
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
Jan Hockmann, Hubertus Hautzel, Kaid Darwiche, et al.
Page
of 73
Search research articles
Search
Showing results (181-190 of 721) with videos related to
Sort By:
Page
of 73
Oncology Research and Treatment
|
November 24, 2021
The Future Role of PET Imaging in Metastatic Breast Cancer
Kim M Pabst, Thomas Decker, David Kersting, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
May 1, 2020
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer
Lale Umutlu, Felix Nensa, Aydin Demircioglu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 13, 2023
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
European Urology Oncology
|
April 25, 2019
Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments
Andrea Farolfi, Wolfgang Fendler, Amir Iravani, et al.
Data in Brief
|
March 5, 2021
Insights into immunometabolism: A dataset correlating the <sup>18</sup>FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer
Tugba Dönmez, Kerstin Höhne, Gernot Zissel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2017
<sup>18</sup>F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?
Julian Kirchner, Cornelius Deuschl, Johannes Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 19, 2019
In Vitro and In Vivo Characterization of an <sup>18</sup>F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts
Susanne Lütje, Gerben M Franssen, Ken Herrmann, et al.
Clinical Nuclear Medicine
|
December 30, 2014
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
Rudolf A Werner, Joachim Brumberg, Alexander Dierks, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 24, 2017
Imaging children suffering from lymphoma: an evaluation of different <sup>18</sup>F-FDG PET/MRI protocols compared to whole-body DW-MRI
Julian Kirchner, Cornelius Deuschl, Bernd Schweiger, et al.
Asian Cardiovascular & Thoracic Annals
|
July 13, 2023
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
Jan Hockmann, Hubertus Hautzel, Kaid Darwiche, et al.
Page
of 73